Taxotere Prostate Cancer New Indication Registration Trial in China

NCT00436839 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Mitoxantrone
DRUG: Prednisone

Sponsor

Sanofi